(Q33449885)

English

Probiotic Bacteria Lactobacillus acidophilus NCFM and Bifidobacterium lactis Bi-07 Versus Placebo for the Symptoms of Bloating in Patients With Functional Bowel Disorders

scientific article published on July 1, 2011

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Probiotic bacteria Lactobacillus acidophilus NCFM and Bifidobacterium lactis Bi-07 versus placebo for the symptoms of bloating in patients with functional bowel disorders: a double-blind study (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Probiotic Bacteria Lactobacillus acidophilus NCFM and Bifidobacterium lactis Bi-07 Versus Placebo for the Symptoms of Bloating in Patients With Functional Bowel Disorders (English)

1 reference

10.1097/MCG.0B013E31820CA4D6

https://api.crossref.org/works/10.1097/MCG.0B013E31820CA4D6

28 November 2024

0 references

0 references

Lactobacillus acidophilus

object named as

Lactobacillus acidophilus

1 reference

based on heuristic

inferred from title

Bifidobacterium lactis

object named as

Bifidobacterium lactis

1 reference

based on heuristic

inferred from title

Olafur S Palsson

2

object named as

Olafur S. Palsson

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21436726

28 November 2024

author name string

Tamar Ringel-Kulka

1

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Danielle Maier

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Ian Carroll

4

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Gregory Leyer

6

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Yehuda Ringel

7

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Joseph A. Galanko

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21436726

28 November 2024

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21436726

28 November 2024

publication date

1 July 2011

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

July 2011

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21436726

28 November 2024

full work available at URL

https://europepmc.org/articles/pmc4372813?pdf=render

Portable Document Format

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21436726

28 November 2024

https://europepmc.org/articles/PMC4372813

online access status

content deliverer

Europe PubMed Central

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21436726

28 November 2024

https://europepmc.org/articles/PMC4372813?pdf=render

Portable Document Format

online access status

content deliverer

Europe PubMed Central

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21436726

28 November 2024

https://doi.org/10.1097/mcg.0b013e31820ca4d6

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21436726

28 November 2024

http://journals.lww.com/00004836-201107000-00009

1 reference

10.1097/MCG.0B013E31820CA4D6

https://api.crossref.org/works/10.1097/MCG.0B013E31820CA4D6

28 November 2024

Journal of Clinical Gastroenterology

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

45

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

518-525

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

VSL#3 improves symptoms in children with irritable bowel syndrome: a multicenter, randomized, placebo-controlled, double-blind, crossover study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4372813

21 June 2018

The burden of IBS: looking at metrics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4372813

21 June 2018

An evidence-based position statement on the management of irritable bowel syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4372813

21 June 2018

Comparison of the complete genome sequences of Bifidobacterium animalis subsp. lactis DSM 10140 and Bl-04

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4372813

21 June 2018

The utility of probiotics in the treatment of irritable bowel syndrome: a systematic review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4372813

21 June 2018

Alterations in the intestinal microbiota and functional bowel symptoms

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4372813

21 June 2018

Prevalence, characteristics, and impact of bloating symptoms in patients with irritable bowel syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4372813

21 June 2018

The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4372813

21 June 2018

Review article: the psychoneuroimmunology of irritable bowel syndrome--an exploration of interactions between psychological, neurological and immunological observations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4372813

21 June 2018

Review article: probiotics and prebiotics in irritable bowel syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4372813

21 June 2018

Prevalence and risk factors for abdominal bloating and visible distention: a population-based study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4372813

21 June 2018

Review article: Probiotics in gastrointestinal and liver diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4372813

21 June 2018

The effect of a nonabsorbed oral antibiotic (rifaximin) on the symptoms of the irritable bowel syndrome: a randomized trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4372813

21 June 2018

Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4372813

21 June 2018

A randomized double-blind placebo-controlled trial of rifaximin in patients with abdominal bloating and flatulence

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4372813

21 June 2018

Costs of irritable bowel syndrome in the UK and US.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4372813

21 June 2018

A randomized controlled trial of a probiotic combination VSL# 3 and placebo in irritable bowel syndrome with bloating

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4372813

21 June 2018

Irritable bowel syndrome in the United States: prevalence, symptom patterns and impact.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4372813

21 June 2018

Cognitive-behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4372813

21 June 2018

A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4372813

21 June 2018

The epidemiology of irritable bowel syndrome in North America: a systematic review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4372813

21 June 2018

Health-related quality of life among persons with irritable bowel syndrome: a systematic review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4372813

21 June 2018

Specific identification and targeted characterization of Bifidobacterium lactis from different environmental isolates by a combined multiplex-PCR approach

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4372813

21 June 2018

Cognitive-behavioral group therapy for patients with irritable bowel syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4372813

21 June 2018

Stool Form Scale as a Useful Guide to Intestinal Transit Time

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4372813

21 June 2018

Clinical trial: the effects of a fermented milk product containing Bifidobacterium lactis DN-173 010 on abdominal distension and gastrointestinal transit in irritable bowel syndrome with constipation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4372813

31 October 2018

Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4372813

31 October 2018

Health status by gastrointestinal diagnosis and abuse history

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4372813

31 October 2018

Quality of life in persons with irritable bowel syndrome: development and validation of a new measure

1 reference

https://pubmed.ncbi.nlm.nih.gov/21436726

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress

1 reference

https://pubmed.ncbi.nlm.nih.gov/21436726

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices

1 reference

https://pubmed.ncbi.nlm.nih.gov/21436726

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lactobacillus and bifidobacterium in irritable bowel syndrome: Symptom responses and relationship to cytokine profiles

1 reference

https://pubmed.ncbi.nlm.nih.gov/21436726

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bloating and abdominal distention: not so poorly understood anymore!

1 reference

https://pubmed.ncbi.nlm.nih.gov/21436726

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota

1 reference

https://pubmed.ncbi.nlm.nih.gov/21436726

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diagnostic performance of rapid tests for detection of fecal calprotectin and lactoferrin and their ability to discriminate inflammatory from irritable bowel syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/21436726

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cognitive factors affect treatment response to medical and psychological treatments in functional bowel disorders

1 reference

https://pubmed.ncbi.nlm.nih.gov/21436726

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1097/MCG.0B013E31820CA4D6

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33449885&oldid=2280638161"